New Jersey A5020 bans spread pricing by pharmacy benefit managers and mandates transparency in their services.
New Jersey A5020 prohibits pharmacy benefit managers from using spread pricing in their contracts with carriers, health benefits plans, and pharmacies. Spread pricing occurs when the contracted price for prescription drugs differs from the amount paid to pharmacies. The bill mandates that pharmacy benefit managers remit 100 percent of rebates, fees, discounts, and other remuneration to the carrier, health benefits plan, or purchaser.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.